位置:首页 > 蛋白库 > JBP1_LEITA
JBP1_LEITA
ID   JBP1_LEITA              Reviewed;         827 AA.
AC   Q9U6M1;
DT   16-JUN-2009, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   03-AUG-2022, entry version 51.
DE   RecName: Full=Thymine dioxygenase JBP1;
DE            EC=1.14.11.6 {ECO:0000269|PubMed:17389644};
DE   AltName: Full=J-binding protein 1;
DE   AltName: Full=Thymidine hydroxylase JBP1;
GN   Name=JBP1;
OS   Leishmania tarentolae (Sauroleishmania tarentolae).
OC   Eukaryota; Discoba; Euglenozoa; Kinetoplastea; Metakinetoplastina;
OC   Trypanosomatida; Trypanosomatidae; Leishmaniinae; Leishmania;
OC   lizard Leishmania.
OX   NCBI_TaxID=5689;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND DNA-BINDING.
RC   STRAIN=tarIVa;
RX   PubMed=10562569; DOI=10.1093/emboj/18.22.6573;
RA   Cross M., Kieft R., Sabatini R., Wilm M., de Kort M., van der Marel G.A.,
RA   van Boom J.H., van Leeuwen F., Borst P.;
RT   "The modified base J is the target for a novel DNA-binding protein in
RT   kinetoplastid protozoans.";
RL   EMBO J. 18:6573-6581(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=TarII;
RX   PubMed=15781496; DOI=10.1093/nar/gki304;
RA   Genest P.-A., ter Riet B., Dumas C., Papadopoulou B., van Luenen H.G.A.M.,
RA   Borst P.;
RT   "Formation of linear inverted repeat amplicons following targeting of an
RT   essential gene in Leishmania.";
RL   Nucleic Acids Res. 33:1699-1709(2005).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF HIS-189; ASP-191;
RP   HIS-239; ARG-255 AND VAL-259.
RX   PubMed=17389644; DOI=10.1093/nar/gkm049;
RA   Yu Z., Genest P.-A., ter Riet B., Sweeney K., DiPaolo C., Kieft R.,
RA   Christodoulou E., Perrakis A., Simmons J.M., Hausinger R.P.,
RA   van Luenen H.G.A.M., Rigden D.J., Sabatini R., Borst P.;
RT   "The protein that binds to DNA base J in trypanosomatids has features of a
RT   thymidine hydroxylase.";
RL   Nucleic Acids Res. 35:2107-2115(2007).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 392-561, DNA-BINDING, MUTAGENESIS
RP   OF GLU-391; LYS-436; ASP-465; GLU-468; 487-GLU-GLU-488; LYS-518; LYS-522;
RP   LYS-524; ASP-525; ARG-532; LYS-535; ASP-536; 540-GLU-GLU-541 AND GLU-553,
RP   SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=21415010; DOI=10.1093/nar/gkr125;
RA   Heidebrecht T., Christodoulou E., Chalmers M.J., Jan S., Ter Riet B.,
RA   Grover R.K., Joosten R.P., Littler D., van Luenen H., Griffin P.R.,
RA   Wentworth P. Jr., Borst P., Perrakis A.;
RT   "The structural basis for recognition of base J containing DNA by a novel
RT   DNA binding domain in JBP1.";
RL   Nucleic Acids Res. 39:5715-5728(2011).
CC   -!- FUNCTION: Dioxygenase that catalyzes the first step of DNA base J
CC       (beta-d-glucosyl-HOMedU) biosynthesis by converting thymine to 5-
CC       hydroxymethyluracil (HOMedU). DNA base J is a hypermodified thymidine
CC       residue found in the genome of kinetoplastid parasites, which is
CC       localized primarily to repetitive DNA, namely the telomeres, and is
CC       implicated in the regulation of antigenic variation. Also specifically
CC       binds to base J-containing DNA (J-DNA). Involved in propagation and
CC       maintenance of DNA base J synthesis initiated by JBP2 by specifically
CC       binding already synthesized DNA base J and propagating J synthesis.
CC       Thymine dioxygenase activity and J-DNA-binding are independent
CC       functions. {ECO:0000269|PubMed:17389644}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate + O2 + thymine = 5-hydroxymethyluracil + CO2 +
CC         succinate; Xref=Rhea:RHEA:10316, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16526, ChEBI:CHEBI:16810, ChEBI:CHEBI:16964,
CC         ChEBI:CHEBI:17821, ChEBI:CHEBI:30031; EC=1.14.11.6;
CC         Evidence={ECO:0000269|PubMed:17389644};
CC   -!- COFACTOR:
CC       Name=Fe(2+); Xref=ChEBI:CHEBI:29033;
CC         Evidence={ECO:0000250|UniProtKB:Q6N021};
CC       Note=Binds 1 Fe(2+) ion per subunit. {ECO:0000250|UniProtKB:Q6N021};
CC   -!- SUBUNIT: Monomer. Binds to DNA as a monomer.
CC       {ECO:0000269|PubMed:21415010}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17389644,
CC       ECO:0000269|PubMed:21415010}. Note=Localizes to discrete spots in the
CC       nucleus, probably the J-rich telomeres.
CC   -!- DOMAIN: The DNA-binding JBP1 domain (DB-JBP1) is necessary and
CC       sufficient for binding to J-DNA.
CC   -!- SIMILARITY: Belongs to the TET family. JBP1 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF182401; AAF01743.1; -; Genomic_DNA.
DR   EMBL; AY842844; AAX81332.1; -; Genomic_DNA.
DR   PDB; 2XSE; X-ray; 1.90 A; A=392-561.
DR   PDBsum; 2XSE; -.
DR   AlphaFoldDB; Q9U6M1; -.
DR   SASBDB; Q9U6M1; -.
DR   SMR; Q9U6M1; -.
DR   PRIDE; Q9U6M1; -.
DR   ABCD; Q9U6M1; 1 sequenced antibody.
DR   VEuPathDB; TriTrypDB:LtaPh_1400300; -.
DR   PhylomeDB; Q9U6M1; -.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0050341; F:thymine dioxygenase activity; TAS:UniProtKB.
DR   GO; GO:0070580; P:base J metabolic process; IMP:UniProtKB.
DR   Gene3D; 1.20.120.1440; -; 1.
DR   InterPro; IPR024779; 2OGFeDO_noxygenase_dom.
DR   InterPro; IPR041241; DB_JBP1.
DR   InterPro; IPR043111; DB_JBP1_sf.
DR   Pfam; PF18526; DB_JBP1; 1.
DR   Pfam; PF12851; Tet_JBP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Dioxygenase; DNA-binding; Iron; Metal-binding; Nucleus;
KW   Oxidoreductase.
FT   CHAIN           1..827
FT                   /note="Thymine dioxygenase JBP1"
FT                   /id="PRO_0000377554"
FT   REGION          62..264
FT                   /note="Thymine dioxygenase"
FT                   /evidence="ECO:0000269|PubMed:17389644"
FT   REGION          364..383
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          392..561
FT                   /note="DNA-binding JBP1 domain"
FT                   /evidence="ECO:0000269|PubMed:17389644"
FT   REGION          539..568
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        539..564
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         189
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000305|PubMed:17389644"
FT   BINDING         191
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000305|PubMed:17389644"
FT   BINDING         239
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000305|PubMed:17389644"
FT   BINDING         255
FT                   /ligand="2-oxoglutarate"
FT                   /ligand_id="ChEBI:CHEBI:16810"
FT                   /evidence="ECO:0000305|PubMed:17389644"
FT   SITE            525
FT                   /note="Involved in J base recognition and binding,
FT                   conferring specificity towards J-DNA"
FT   MUTAGEN         189
FT                   /note="H->A: Impairs DNA base J biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:17389644"
FT   MUTAGEN         191
FT                   /note="D->A: Impairs DNA base J biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:17389644"
FT   MUTAGEN         239
FT                   /note="H->A: Impairs DNA base J biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:17389644"
FT   MUTAGEN         255
FT                   /note="R->A: Impairs DNA base J biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:17389644"
FT   MUTAGEN         259
FT                   /note="V->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:17389644"
FT   MUTAGEN         391
FT                   /note="E->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:21415010"
FT   MUTAGEN         436
FT                   /note="K->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:21415010"
FT   MUTAGEN         465
FT                   /note="D->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:21415010"
FT   MUTAGEN         468
FT                   /note="E->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:21415010"
FT   MUTAGEN         487..488
FT                   /note="EE->AA: No effect."
FT                   /evidence="ECO:0000269|PubMed:21415010"
FT   MUTAGEN         518
FT                   /note="K->A: Decreases binding affinity for both J-DNA and
FT                   normal DNA."
FT                   /evidence="ECO:0000269|PubMed:21415010"
FT   MUTAGEN         522
FT                   /note="K->A: Decreases binding affinity for both J-DNA and
FT                   normal DNA."
FT                   /evidence="ECO:0000269|PubMed:21415010"
FT   MUTAGEN         524
FT                   /note="K->A: Slightly decreases binding affinity for both
FT                   J-DNA and normal DNA."
FT                   /evidence="ECO:0000269|PubMed:21415010"
FT   MUTAGEN         525
FT                   /note="D->A: Abolishes preference for J-DNA-binding."
FT                   /evidence="ECO:0000269|PubMed:21415010"
FT   MUTAGEN         532
FT                   /note="R->A: Decreases binding affinity for both J-DNA and
FT                   normal DNA."
FT                   /evidence="ECO:0000269|PubMed:21415010"
FT   MUTAGEN         535
FT                   /note="K->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:21415010"
FT   MUTAGEN         536
FT                   /note="D->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:21415010"
FT   MUTAGEN         540..541
FT                   /note="EE->AA: No effect."
FT                   /evidence="ECO:0000269|PubMed:21415010"
FT   MUTAGEN         553
FT                   /note="E->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:21415010"
FT   HELIX           396..401
FT                   /evidence="ECO:0007829|PDB:2XSE"
FT   HELIX           402..406
FT                   /evidence="ECO:0007829|PDB:2XSE"
FT   HELIX           408..411
FT                   /evidence="ECO:0007829|PDB:2XSE"
FT   TURN            412..414
FT                   /evidence="ECO:0007829|PDB:2XSE"
FT   HELIX           417..444
FT                   /evidence="ECO:0007829|PDB:2XSE"
FT   STRAND          455..457
FT                   /evidence="ECO:0007829|PDB:2XSE"
FT   HELIX           458..478
FT                   /evidence="ECO:0007829|PDB:2XSE"
FT   HELIX           485..505
FT                   /evidence="ECO:0007829|PDB:2XSE"
FT   TURN            511..514
FT                   /evidence="ECO:0007829|PDB:2XSE"
FT   HELIX           516..527
FT                   /evidence="ECO:0007829|PDB:2XSE"
FT   HELIX           539..556
FT                   /evidence="ECO:0007829|PDB:2XSE"
FT   TURN            557..559
FT                   /evidence="ECO:0007829|PDB:2XSE"
SQ   SEQUENCE   827 AA;  93403 MW;  5A4B502DE70A4BFE CRC64;
     MEPDSKKVKL DIFNFPTTRE TRTPEEVAES YAEAVKSHPF YDNVHSVVDF YDSGTIKDGR
     GQIIGVVLRE ALPKYAASMA SELLTSAAVR TSLRSMMFGG EPPLSGIAGY FDYRGSPVEL
     KSRKTSFTYE HEAAWPAVFP VVDYVSEIYR HVAPERWKAQ NDAIPDLVRI HGTPFSTLTI
     NSRFRTASHT DVGDFDAGYS CIACLDGQFK GLALSFDDFG INVLLQPRDV MIFDSHHFHS
     NTEVELSFSG EDWKRLTCVF YYRAALGEPA SYAEYQRRLE KSKTDTRFTP VVHHVRVKEN
     GTSVNRPSPV YPISQSPFWV PMVAHCLQHC ASAAQCVHEA MTADGSRLAE MMFGESLSTS
     DGIPLRGEDE KVKANGDSTP RPLSRLGGFS ETNLMVSTAV EKKKYLDSEF LLHCISAQLL
     DMWKQARARW LELVGKEWAH MLALNPERKD FLWKNQSEMN SAFFDLCEVG KQVMLGLLGK
     EVALPKEEQA FWIMYAVHLS AACAEELHMP EVAMSLRKLN VKLKDFNFGG TRYFKDMPPE
     EKKRRMERKQ RIEEARRHGM PSGSHEKRAN WLTNDSFDYQ TEDCVIDYAQ HKWVLPALHA
     KEVTKTVRTG ELPTTERVVR VLVVIPDPQS KLENVDCKLE VPDMVGSSSE WERLMSSPAV
     HRVLSAAQRN LQLPDSVTHG NVQTHFAFHS TLPTDIYDFV VLQHVLSRIP DDAQASAYIR
     RAAALCSGCL FVVETDVQCR QYYTLKYSIR CSYDTVAPLF FQQLHRVCYG TKTARVRTKG
     ELESLIPTVC CARYKLQGSP LNTTVHVVSP FPSCEVQNLS SALCDRA
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024